Led by Medable, the multi-company effort is geared toward ramping up development of treatments, diagnostics and other solutions for the pandemic-causing virus.
The pharmaceutical analysis firm is continuing its contract analytical laboratory services running, with changes designed to keep people and products safe.
Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.
The health data specialists look at real-world evidence and real-world data, and how clinical trial sites and sponsors can make the best use of such information tools.
The EndPandemic National Data Consortium has grown to six life-sciences and information-technology organizations, joining to collaborate on research data.
The health technology company is offering decentralized solutions enabling clinical trials for respiratory treatments to continue at participants’ homes.
Amid the spread of the pandemic, Convergency has announced the launch of a cloud-based technology platform to enable research processes to keep on going remotely.
With the acquisition of Weibel, SHL Medical looks to the development of novel drug delivery systems for self-administration, answering a need for improved patient-centricity in the sector.
Bold is on the hunt for supporters among the industry to help evaluate its investigational anti-cancer therapy as a potential coronavirus treatment, after seeing related elements.
